GPX4 and Alzheimer disease: Conversely, PhM, as well as concurrent administration of MH or ZC with AlCl3, significantly raised the GPX4 brain content by 140%, 250%, and 290%, respectively, resulting in neuroprotective effects in contrast to the AD group.